| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 4229 |
| 1 | METHOTREXATE | 2875 |
| 2 | ADALIMUMAB | 2558 |
| 3 | ETANERCEPT | 2140 |
| 4 | PREDNISONE | 1975 |
| 5 | TOFACITINIB | 1894 |
| 6 | LEFLUNOMIDE | 1865 |
| 7 | ACETAMINOPHEN | 1778 |
| 8 | TOCILIZUMAB | 1675 |
| 9 | RITUXIMAB | 1601 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRICLOSAN | 134 | 0.2322 |
| 1 | AMMONIUM CHLORIDE | 26 | 0.1040 |
| 2 | AZATHIOPRINE SODIUM | 240 | 0.0946 |
| 3 | GOLIMUMAB | 1128 | 0.0896 |
| 4 | NICOTINAMIDE | 217 | 0.0849 |
| 5 | CLEAR MINT, GEL TOOTHPASTE | 92 | 0.0839 |
| 6 | SODIUM FLUORIDE F18 | 92 | 0.0833 |
| 7 | SODIUM FLUORIDE F-18 | 92 | 0.0830 |
| 8 | GOLD | 454 | 0.0782 |
| 9 | ONASEMNOGENE ABEPARVOVEC-XIOI | 148 | 0.0641 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 3395 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 3032 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2975 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 2905 |
| 4 | Antirheumatic Agent [EPC] | 1865 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 1813 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 1743 |
| 7 | Aminosalicylate [EPC] | 1712 |
| 8 | Vitamin C [EPC] | 1669 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 1559 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 600 | 0.8721 |
| 1 | Provitamin D2 Compound [EPC] | 1331 | 0.0447 |
| 2 | Neurokinin 3 Receptor Antagonist [EPC] | 98 | 0.0426 |
| 3 | Interleukin-17A Antagonist [EPC] | 1348 | 0.0362 |
| 4 | CD123 Interaction [EPC] | 19 | 0.0353 |
| 5 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 422 | 0.0317 |
| 6 | Polyene Antimicrobial [EPC] | 13 | 0.0317 |
| 7 | CD3-directed Antibody [EPC] | 22 | 0.0306 |
| 8 | l-Thyroxine [EPC] | 1 | 0.0204 |
| 9 | l-Triiodothyronine [EPC] | 1 | 0.0196 |